Neurotone AI Launches Tinnitus Pro
Neurotone AI has launched Tinnitus Pro, a personalized digital tinnitus therapy platform that blends sound therapy, CBT-based tools, and clinician-connected monitoring.
Category: Tinnitus Therapy
Tinnitus Therapy
Latest
Tinnitus Therapy
Latest
Neuromod Closes €10 Million Financing to Accelerate Commercialization of Lenire
Neuromod Devices Ltd. has secured €10 million in oversubscribed equity financing to expand the availability of its FDA-approved tinnitus treatment device, Lenire.
Tinnitus Therapy
Latest
Neuromod’s Tinnitus Treatment Device Expands Availability in Spain
Lenire’s Spanish launch began in Barcelona. This latest expansion brings the number of clinics in Spain providing Lenire to four.
Why the One-Size-Fits-All Approach to Tinnitus is Not Successful
Even though there is no cure for tinnitus today, good approaches that significantly reduce the burden of affected individuals are available. Therefore, it is hoped that the message to sufferers that they have to “live with their tinnitus” will become less and less pronounced.
Read More
University of Auckland Researchers See Results with New Tinnitus Therapy
After 20 years searching for a cure for tinnitus, researchers at the University of Auckland are excited by ‘encouraging results’ from a clinical trial of a mobile-phone-based therapy, according to an article on the University’s website.
Read More
Lenire Tinnitus Device Now Available in Denmark
Neuromod Devices Ltd has reached an agreement with Specialklinikken Borgå ApS, a Danish provider of private care for tinnitus, to make its Lenire device available in Denmark.
Read More
Neuromod Publishes Clinical Trial for Lenire Device
An international team, including a University of Minnesota professor, has published a second large clinical trial for a novel neuromodulation device, Lenire, that could reduce symptoms for millions worldwide with tinnitus, commonly described as “ringing in the ears.” Researchers published the results of the Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2 (TENT-A2) clinical trial in “Nature – Scientific Reports.” An article detailing the research appears on the University of Minnesota website.
Read More
Neuromod Publishes Results of TENT-A2 Study
results of the company’s TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in “Nature – Scientific Reports” in a paper titled “Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial.”
Read More
New Textbook: “Combatting Tinnitus” by John Greer Clark
Tinnitus has plagued mankind for millennia. Yet, too often when those who have tinnitus seek professional help, they are told they will have to learn to live with it.
Read More
Book Review: Living Well With Tinnitus
According to the British Tinnitus Association, around 30% of people experience tinnitus, with 13% (1 in 8) having persistent tinnitus. For such a common condition, many people do not understand the impact it can have.
Read More
Usability of Bimodal Neuromodulation to Treat Tinnitus
It is reported that 10-15% of the global adult population suffers from tinnitus 1-4, the chronic phantom auditory percept that has been attributed to abnormal firing patterns in the brain.4 According to the American Tinnitus Association (ATA), 45 million Americans reported experiencing tinnitus in the US Centers for Disease Control (CDC) National Health and Nutritional Examination Survey.
Read More
Could Neuralink Neuroprosthetic Device Help Tinnitus?
Australian author and academic David Tuffley challenges bold claims that a neuroprosthetic device developed by Elon Musk’s Neuralink start-up company could “cure tinnitus” within five years, in an article on “The Conversation” website.
Read More
Plural Publishing Releases Tinnitus Textbook
Edited by Aniruddha Deshpande and James Hall, III, the new textbook provides up-to-date and evidence-based information on tinnitus prevention, assessment, and management.
Read More
Treble Health and Oto Partner for Telehealth Tinnitus Support
US-based audiology telehealth company Treble Health and Oto, the UK-based digital health startup for tinnitus support, have announced a collaboration to allow Oto app users to access Treble Health’s team of audiologists for telehealth consultations.
Read More
Ótologie Tinnitus Care Offers Free Assessments During Tinnitus Week
Specialist tinnitus service, Ótologie Tinnitus Care is offering free assessments to people living with tinnitus to mark its sponsorship of the British Tinnitus Association’s Tinnitus Week, which runs from February 7-13, 2022.
Read More
‘Wired’ Article Suggests Apps and Devices to Help with Tinnitus
Described as a “phantom sound generated by the brain” by audiologist Julie Prutsman, tinnitus is a common condition experienced as ringing or buzzing in the ears, often caused by loud noise exposure. While there is no “cure” for tinnitus, there are methods of coping, according to a recent article in “Wired.”
Read More
Neuromod Launches Ótologie Tinnitus Telehealth Service
Medical device company, Neuromod Devices Ltd, announced that it has launched Ótologie, a “specialist telehealth service for tinnitus.” This new service will provide tinnitus patients, throughout the United Kingdom and Europe, with a private care option to avoid waiting lists and give them immediate access to treatment from its telehealth service.
Read More
Cicadas’ Buzzing Sound Could Worsen Tinnitus
With this year’s return of cicadas, many will view the mostly harmless insects as an annoyance. However, the bugs’ high-pitched buzzing sound — which can be loud enough to drown out a jet plane flying overhead — could potentially worsen tinnitus.
Read More